Market Performance of Anti-infective Drugs in New Medical Insurance Catalogue in 2024 |
2025-01-16 |
Indian Pharmaceutical Market Grows 6.1% in October Against the Trend |
2024-11-15 |
Global healthcare encounters formidable challenges with AMR and sepsis, eyes pathogen sequencing to manage spread |
2024-09-20 |
Huadong Medicine Aussino Biotech Announce Exclusive Strategic Collaboration on Improved Oral Formulation of Edaravone in China Beyond |
2024-07-19 |
Hospital Director Illegally Profited 27 Million, Exposed by Discipline Inspection Commission! |
2024-07-19 |
Rising heart issues warrant urgent need for proactive heart health monitoring: Dr Manoj Durairaj |
2024-07-12 |
Jan Aushadhi Kendras report 36.7% growth in sales in May |
2024-07-03 |
Genetic Signatures’ EasyScreen gastrointestinal parasite detection kit receives US FDA clearance |
2024-06-07 |
Adicet Bio receives US FDA fast track designation for ADI-001 for class IV lupus nephritis |
2024-06-07 |
US EPA, US FDA & USDA issue joint regulatory plan for biotechnology |
2024-05-14 |
WHO publishes new guidance aims to reduce bloodstream infections from catheter use |
2024-05-11 |
Top 10 countries accounted for Indias 63% of Ayush herbal products export in 2023-24 |
2024-05-11 |
Merck Collaborates with AI Biotech in times="32".4 Billion ADC Drug Development |
2024-04-17 |
Signant Health unveils next-level advancements in efficient, compliant IP management with updates to its clinical supply solutions |
2024-03-08 |
Unveiling the Pricing of Chinas Fifth Domestic CAR-T Therapy: Can Annual Sales Reach 1 Billion? |
2024-03-08 |
Unveiling the Future Direction of Innovative Medicines in 2024 |
2024-03-08 |
The Race to Market: Five Potential Blockbuster GLP-1 Therapies in 2024 |
2024-02-22 |
Enveric selects development candidates from EVM301 Series based on potential to minimize or eliminate the hallucinogenic effect of psychedelic-derived compounds |
2023-12-08 |
World Health Organization releases guidelines on chronic low back pain |
2023-12-08 |
Merck announces positive results from phase 2 KeyVibe-002 trial evaluating coformulation of vibostolimab pembrolizumab in previously treated patients with metastatic NSCLC |
2023-12-08 |
Global cell gene therapy market projected to expat 24% CAGR |
2023-11-15 |
Gilead Sciences Reports Q3 2023 Financial Results |
2023-11-10 |
Amgen to present results from phase 4 FOREMOST study of Otezla to treat early oligoarticular psoriatic arthritis at ACR 2023 |
2023-11-09 |
India’s mental healthcare grapples with stigma, inadequate resources & insufficient expertise |
2023-11-03 |
The Future of Personalized Medicine |
2023-11-03 |
Sanofi Shares Rebound as Company Announces Consumer Health Division Spinoff |
2023-11-03 |
Eli Lilly Collaborates with Redwire Corporation to Explore Drug Manufacturing in Space |
2023-11-03 |
Novartis Acquires FDA Priority Review Voucher from bluebird bio for $103 Million |
2023-11-03 |
Pfizer Receives Conditional Approval for Tislelizumab in the Treatment of Relapsed or Refractory Extranodal NK/T-cell Lymphoma (ENKTL) |
2023-11-03 |
Safety warnings to be provided to all patients with each medicine containing valproate they get under new law: MHRA |
2023-10-13 |
Novo Nordisk halts phase III FLOW trial of semaglutide early due to strong efficacy |
2023-10-13 |
Leqembi Receives Approval in Japan for the Treatment of Alzheimers Disease: A Milestone in Slowing Cognitive Decline |
2023-10-13 |